Today, the European Commission and its Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) published the Memorandum on weight of evidence and uncertainties.
The Commission has adopted an Implementing Decision on the list of communicable diseases and related special health issues as well as relevant case definitions to be monitored through the EU’s epidemiological surveillance network.
The bilateral regulatory dialogue between EU and US allowed the strategic partners to review their ongoing cooperative initiatives, discuss strategic priorities for the coming years and further strengthen the continuous close collaboration with specific action in the field of pharmaceuticals.
In Luxembourg today, the European Commissioner for Health and Food Safety Vytenis Andriukaitis launched the first meeting of the Joint Action on Health Inequalities ''Health Equity in Europe''. In his speech, the Commissioner expressed his belief that the broad and ambitious scope of this Joint Action would be a key piece of work to promote greater equity in health outcomes and reduce inter-country differences.
By Director of public health, country knowledge, crisis management at the Commission's Directorate General for Public Health and Food Safety John-F. Ryan and Director of the Commission's Joint Research Centre, Directorate F, Health, Consumers and Reference Materials, Dr Elke Anklam.
The general public is invited to discuss and debate Public Health issues. Please register to attend the event, or watch the Dialogue online.
This year, the theme of the award is “Empowering people and ensuring inclusiveness and equality”. Applications can be submitted until 14 September 2018.
Commissioner for Health and Food Safety, Vytenis Andriukaitis, reminds the importance of blood donation to help save lives.
By Director General of the Directorate-General for Health and Food Safety Xavier Prats Monné.
Lithuania and Ireland have joined today the list of EU countries recognised as capable to carry out good manufacturing practice (GMP) with regard to inspections of sites that manufacture human medicines. This brings the total number of countries accepted by the FDA to 14.